Mohs Micrographic Surgery is a surgical procedure for removing certain common types of skin cancer, including basal cell carcinoma and squamous cell carcinoma. The advantage of this procedure is the precision in which the lesion can be removed, including the deeper sections of the skin cancer, while leaving as much healthy skin remaining as possible.
By leaving as much uninvolved skin intact as possible, the procedure minimizes the wound after surgery. The cure rate is very high at approximately 95% for an initial treatment of skin cancer at five years.
The procedure involves removing one thin layer of tissue at a time. After each layer is removed, it is carefully examined under a microscope. Mohs Surgery does not require general anesthesia and can be performed in our office surgical suites. Most Mohs surgeries are performed on the face, head, and neck to remove basal and squamous cell carcinomas while minimizing the size of the scar.
Why Choose a Fellowship Trained Mohs Surgeon?
Mohs micrographic surgery has set a new standard in skin cancer treatment. An increasing number of physicians are performing Mohs surgery, which is now widely accepted as the most effective treatment for most types of skin cancer on the head and neck or other sensitive areas.
When it comes to skin cancer treatment, Philadelphia patients deserve no less than the best.
ACMS – Committed to Superior Care
The ACMS was established by Dr. Frederic Mohs himself, and its fellowship training program is generally acknowledged as the benchmark in Mohs surgery training. Through an extensive application and interview process, only the most qualified physicians are selected by the ACMS to participate in a fellowship program. Participants must undergo a rigorous 1 to 2-year training program subsequent to completing a residency in dermatology.